Drugs that contain Elagolix Sodium,estradiol,norethindrone Acetate; Elagolix Sodium
1. Drug name - ORIAHNN (COPACKAGED)
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7419983 | ABBVIE INC | Gonadotropin-releasing hormone receptor antagonists and methods related thereto |
Jul, 2024
(1 year, 9 months from now) | |
| US7056927 | ABBVIE INC | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
Sep, 2024
(1 year, 11 months from now) | |
| CN1819829A | ABBVIE INC | As Gonadotropin-Releasing Hormone Receptor Antagonists And -2 - 4-Dione Derivatives |
Jul, 2024
(1 year, 9 months from now) | |
| CN100424078C | ABBVIE INC | As Gonadotropin-Releasing Hormone Receptor Antagonists And -2 - 4-Dione Derivatives |
Jul, 2024
(1 year, 9 months from now) | |
| IN312234B | ABBVIE INC | Pyrimidine-2, 4-Dione Based Compounds As Gonadotropin-Releasing Hormone Receptor Antagonists |
Jul, 2024
(1 year, 9 months from now) | |
| IN200600072P1 | ABBVIE INC | Pyrimidine-2,4-Dione Derivatives As Gonadotropin-Releasing Hormone Receptor Antagonists |
Jul, 2024
(1 year, 9 months from now) | |
| EP1646389B1 | ABBVIE INC | Pyrimidine-2,4-Dione Derivatives As Gonadotropin-Releasing Hormone Receptor Antagonists |
Jul, 2024
(1 year, 9 months from now) | |
| EP1646389A1 | ABBVIE INC | Pyrimidine-2,4-Dione Derivatives As Gonadotropin-Releasing Hormone Receptor Antagonists |
Jul, 2024
(1 year, 9 months from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10881659 | ABBVIE INC | Methods of treating heavy menstrual bleeding |
Mar, 2034
(11 years from now) | |
| US11045470 | ABBVIE INC | Methods of treating heavy menstrual bleeding |
Mar, 2034
(11 years from now) | |
Treatment: Management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids)
Dosage: CAPSULE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 300MG BASE,1MG,0.5MG; EQ 300MG BASE | CAPSULE;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.